Merck & Co., Inc., Rahway, N.J., USA Announces First-Quarter 2026 Financial Results; Highlights Significant Regulatory Approvals and Clinical Milestones

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. CBRS
2. FDX
3. KBH
4. HON
5. MRK
6. HTZ
7. INFY
8. HONA
9. TTWO
10. USO

Go back to Merck & Co., Inc., Rahway, N.J., USA Announces First-Quarter 2026 Financial Results; Highlights Significant Regulatory Approvals and Clinical Milestones
Merck & Co. (NYSE: MRK) Delayed: 119.60 --0 (-0%)
Previous Close $119.60    52 Week High $65.46 
Open $119.60    52 Week Low $47.97 
Day High $119.60    P/E 81.36 
Day Low $119.60    EPS $1.47 
Volume 5,219